Belgium· BE-AMP-SAM241552-00
Rilatine Modified Release 40 mg
A methylphenidate product containing methylphenidate hydrochloride, registered in Belgium by InfectoPharm Arzneimittel und Consilium. The same ATC class is registered in 18 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Methylphenidate is registered in 18 of 19 countries.
Countries holding a registration under ATC N06BA04 (methylphenidate), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Methylphenidate · ATC N06BA04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methylphenidate costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.56 in France to $1.87 in Switzerland — a ×3.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Methylphenidate · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.87
- IT Italy$0.68
- US United States$0.56 (acquisition cost)
- FR France$0.56
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Methylphenidate Hydrochloride
- Manufacturer
- InfectoPharm Arzneimittel und Consilium
- Country
- Belgium (BE)
- ATC code
- N06BA04
- ATC class
- Methylphenidate
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1766633
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
196 interactions on record for methylphenidate.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylphenidate · interactions on record
196 records
- 12 severe
- 45 moderate
- 3 minor
- 128 info
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- CocaineN01BC01severe
8 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methylphenidate in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMETADATE CDAytu BioPharma, Inc.
- SwedenAffenid 40 mg Kapsel med modifierad frisättning, hårdZentiva k.s.
- NetherlandsEquasym XL 40 mg, capsule met gereguleerde afgifte, hardTakeda Pharmaceuticals International AG Ireland Branch
- United KingdomFocusim XL 40mg capsulesStrides Pharma UK Ltd
- SpainEQUASYM 40 MG CAPSULAS DURAS DE LIBERACION MODIFICADATakeda Pharmaceuticals International Ag Ireland Branch
- IcelandMedikinet CRMedice Arzneimittel Pütter GmbH & Co. KG*
- PolandAdehaderHumantis GmbH
- FranceMEDIKINET 40 mg, gélule à libération modifiéeMEDICE ARZNEIMITTEL PÜTTER (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Concerta, Conmethyl
- Bulgaria · Концерта
- Cyprus · Concerta
- Czechia · Balipre, Concerta
- Germany · 5 Mg, Medikinet, 50 Mg, Medikinet Adult
- Denmark · Concerta, Equasym Depot
- Estonia · Affenid, Concerta
- Spain · Atenza, Concerta
- Finland · Atexam, Concerta
- France · Concerta Lp, Lp
- United Kingdom (Northern Ireland) · Addepta Xl, Affenid Xl
- Greece · Concerta
- Croatia · Concerta, Mefeda
- Hungary · Ritalin, Ritalin La
- Ireland · Concerta Xl, Equasym Xl
- Iceland · Concerta, Equasym Depot
- Italy · Equasym, Medikinet
- Liechtenstein · Concerta, Tuzulby
- Lithuania · Concerta, Medikinet
- Luxembourg · Concerta, Equasym Xr
- Latvia · Medikinet, Medikinet Xl
- Malta · Concerta, Concerta Xl
- Netherlands · Concerta, Equasym Xl
- Norway · Concerta, Delmosart
- Poland · Adehader, Atenza
- Portugal · Atexam, Concerta
- Romania · Clorhidrat De Metilfenidat G.L. Pharma, Concerta
- Sweden · Affenid, Concerta
- Slovenia · Concerta
- Slovakia · Balipre, Concerta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfd62942-b65f-4a77-bf3c-f047ad88cc64 GET /v1/drugs/dfd62942-b65f-4a77-bf3c-f047ad88cc64?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Modified-release capsule, hard",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Rilatine Modified Release 40 mg",
"name_fr": "Rilatine Modified Release 40 mg",
"name_nl": "Rilatine Modified Release 40 mg",
"amp_code": "SAM241552-00",
"strengths": [
"40.0000",
"40.0000"
],
"pack_count": 2,
"substances": [
"Methylphenidate Hydrochloride",
"Sugar Spheres"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Methylphenidate",
"authorisation_numbers": [
"BE241552"
]
}See everything about methylphenidate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.